Analysis of clinical studies with natural and synthetic luteinizing hormone releasing hormone in man

A. J. Kastin, Andrew V Schally, A. Zarate, A. Arimura, D. Gonzalez-Barcena, C. A. Medeiros-Neto, D. S. Schalch

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

It was first determined that luteinizing hormone-releasing hormone (LH-RH) obtained from porcine, bovine, and ovine sources was biologically active in man. When the structure of porcine LH-RH was determined, synthetic material was also found active in man. Studies indicated that FSH as well as LH were released from the pituitary into the peripheral circulation by both the natural and synthetic LH-RH. Although blood basal levels of LH and FSH are increased after the menopause a further increase was produced by LH-RH, either naturally or synthetically. In other conditions (Klinefelter's and Turner's syndromes) with naturally occurring elevations of blood levels of LH and FSH, further release was also obtained by both natural and synthetic LH-RH. In subjects pretreated with 200 mg/day clomiphene additional rapid increase was obtained. In patients with pituitary tumors and acromegaly the response was variable. However, 1 patient who did not release gonadotropins after LH-RH did release thyrotropin (TSH) after receiving TSH-releasing hormone. The effects of LH-RH administration on other steroids in the blood are currently being investigated. Routes other than the intravenous administration are being tried, e.g., subcutaneous and intramuscular. It has been found that a child's pituitary can release LH and FSH after administration of porcine LH-RH. In Kallmann's syndrome of hypogonadotropic hypogonadism with anosmia, a small increase of gonadotropin release has been shown after rapid intravenous injection of LH-RH. Long duration of intravenous infusion of LH-RH with 2 supplementary intramuscular injections has produced ovulation in a patient primed with an FSH-containing material (Pergonal). In other experiments patients pretreated with clomiphene had an increased incidence of ovulation. In men with oligospermia only slight improvement has been obtained. Most of the data presented were obtained using highly purified material of porcine origin.

Original languageEnglish
Pages (from-to)1305-1313
Number of pages9
JournalIsrael Journal of Medical Sciences
Volume10
Issue number10
StatePublished - Dec 1 1974
Externally publishedYes

Fingerprint

Gonadotropin-Releasing Hormone
Swine
Kallmann Syndrome
Clomiphene
Blood
Ovulation
Gonadotropins
Clinical Studies
Menotropins
Klinefelter Syndrome
Oligospermia
Turner Syndrome
Acromegaly
Intramuscular Injections
Hormones
Pituitary Neoplasms
Thyrotropin
Menopause
Intravenous Infusions
Intravenous Injections

ASJC Scopus subject areas

  • Bioengineering
  • Medicine(all)

Cite this

Kastin, A. J., Schally, A. V., Zarate, A., Arimura, A., Gonzalez-Barcena, D., Medeiros-Neto, C. A., & Schalch, D. S. (1974). Analysis of clinical studies with natural and synthetic luteinizing hormone releasing hormone in man. Israel Journal of Medical Sciences, 10(10), 1305-1313.

Analysis of clinical studies with natural and synthetic luteinizing hormone releasing hormone in man. / Kastin, A. J.; Schally, Andrew V; Zarate, A.; Arimura, A.; Gonzalez-Barcena, D.; Medeiros-Neto, C. A.; Schalch, D. S.

In: Israel Journal of Medical Sciences, Vol. 10, No. 10, 01.12.1974, p. 1305-1313.

Research output: Contribution to journalArticle

Kastin, AJ, Schally, AV, Zarate, A, Arimura, A, Gonzalez-Barcena, D, Medeiros-Neto, CA & Schalch, DS 1974, 'Analysis of clinical studies with natural and synthetic luteinizing hormone releasing hormone in man', Israel Journal of Medical Sciences, vol. 10, no. 10, pp. 1305-1313.
Kastin AJ, Schally AV, Zarate A, Arimura A, Gonzalez-Barcena D, Medeiros-Neto CA et al. Analysis of clinical studies with natural and synthetic luteinizing hormone releasing hormone in man. Israel Journal of Medical Sciences. 1974 Dec 1;10(10):1305-1313.
Kastin, A. J. ; Schally, Andrew V ; Zarate, A. ; Arimura, A. ; Gonzalez-Barcena, D. ; Medeiros-Neto, C. A. ; Schalch, D. S. / Analysis of clinical studies with natural and synthetic luteinizing hormone releasing hormone in man. In: Israel Journal of Medical Sciences. 1974 ; Vol. 10, No. 10. pp. 1305-1313.
@article{9aaf476995cf423da6a1290e8b0861bf,
title = "Analysis of clinical studies with natural and synthetic luteinizing hormone releasing hormone in man",
abstract = "It was first determined that luteinizing hormone-releasing hormone (LH-RH) obtained from porcine, bovine, and ovine sources was biologically active in man. When the structure of porcine LH-RH was determined, synthetic material was also found active in man. Studies indicated that FSH as well as LH were released from the pituitary into the peripheral circulation by both the natural and synthetic LH-RH. Although blood basal levels of LH and FSH are increased after the menopause a further increase was produced by LH-RH, either naturally or synthetically. In other conditions (Klinefelter's and Turner's syndromes) with naturally occurring elevations of blood levels of LH and FSH, further release was also obtained by both natural and synthetic LH-RH. In subjects pretreated with 200 mg/day clomiphene additional rapid increase was obtained. In patients with pituitary tumors and acromegaly the response was variable. However, 1 patient who did not release gonadotropins after LH-RH did release thyrotropin (TSH) after receiving TSH-releasing hormone. The effects of LH-RH administration on other steroids in the blood are currently being investigated. Routes other than the intravenous administration are being tried, e.g., subcutaneous and intramuscular. It has been found that a child's pituitary can release LH and FSH after administration of porcine LH-RH. In Kallmann's syndrome of hypogonadotropic hypogonadism with anosmia, a small increase of gonadotropin release has been shown after rapid intravenous injection of LH-RH. Long duration of intravenous infusion of LH-RH with 2 supplementary intramuscular injections has produced ovulation in a patient primed with an FSH-containing material (Pergonal). In other experiments patients pretreated with clomiphene had an increased incidence of ovulation. In men with oligospermia only slight improvement has been obtained. Most of the data presented were obtained using highly purified material of porcine origin.",
author = "Kastin, {A. J.} and Schally, {Andrew V} and A. Zarate and A. Arimura and D. Gonzalez-Barcena and Medeiros-Neto, {C. A.} and Schalch, {D. S.}",
year = "1974",
month = "12",
day = "1",
language = "English",
volume = "10",
pages = "1305--1313",
journal = "Israel Medical Association Journal",
issn = "1565-1088",
publisher = "Israel Medical Association",
number = "10",

}

TY - JOUR

T1 - Analysis of clinical studies with natural and synthetic luteinizing hormone releasing hormone in man

AU - Kastin, A. J.

AU - Schally, Andrew V

AU - Zarate, A.

AU - Arimura, A.

AU - Gonzalez-Barcena, D.

AU - Medeiros-Neto, C. A.

AU - Schalch, D. S.

PY - 1974/12/1

Y1 - 1974/12/1

N2 - It was first determined that luteinizing hormone-releasing hormone (LH-RH) obtained from porcine, bovine, and ovine sources was biologically active in man. When the structure of porcine LH-RH was determined, synthetic material was also found active in man. Studies indicated that FSH as well as LH were released from the pituitary into the peripheral circulation by both the natural and synthetic LH-RH. Although blood basal levels of LH and FSH are increased after the menopause a further increase was produced by LH-RH, either naturally or synthetically. In other conditions (Klinefelter's and Turner's syndromes) with naturally occurring elevations of blood levels of LH and FSH, further release was also obtained by both natural and synthetic LH-RH. In subjects pretreated with 200 mg/day clomiphene additional rapid increase was obtained. In patients with pituitary tumors and acromegaly the response was variable. However, 1 patient who did not release gonadotropins after LH-RH did release thyrotropin (TSH) after receiving TSH-releasing hormone. The effects of LH-RH administration on other steroids in the blood are currently being investigated. Routes other than the intravenous administration are being tried, e.g., subcutaneous and intramuscular. It has been found that a child's pituitary can release LH and FSH after administration of porcine LH-RH. In Kallmann's syndrome of hypogonadotropic hypogonadism with anosmia, a small increase of gonadotropin release has been shown after rapid intravenous injection of LH-RH. Long duration of intravenous infusion of LH-RH with 2 supplementary intramuscular injections has produced ovulation in a patient primed with an FSH-containing material (Pergonal). In other experiments patients pretreated with clomiphene had an increased incidence of ovulation. In men with oligospermia only slight improvement has been obtained. Most of the data presented were obtained using highly purified material of porcine origin.

AB - It was first determined that luteinizing hormone-releasing hormone (LH-RH) obtained from porcine, bovine, and ovine sources was biologically active in man. When the structure of porcine LH-RH was determined, synthetic material was also found active in man. Studies indicated that FSH as well as LH were released from the pituitary into the peripheral circulation by both the natural and synthetic LH-RH. Although blood basal levels of LH and FSH are increased after the menopause a further increase was produced by LH-RH, either naturally or synthetically. In other conditions (Klinefelter's and Turner's syndromes) with naturally occurring elevations of blood levels of LH and FSH, further release was also obtained by both natural and synthetic LH-RH. In subjects pretreated with 200 mg/day clomiphene additional rapid increase was obtained. In patients with pituitary tumors and acromegaly the response was variable. However, 1 patient who did not release gonadotropins after LH-RH did release thyrotropin (TSH) after receiving TSH-releasing hormone. The effects of LH-RH administration on other steroids in the blood are currently being investigated. Routes other than the intravenous administration are being tried, e.g., subcutaneous and intramuscular. It has been found that a child's pituitary can release LH and FSH after administration of porcine LH-RH. In Kallmann's syndrome of hypogonadotropic hypogonadism with anosmia, a small increase of gonadotropin release has been shown after rapid intravenous injection of LH-RH. Long duration of intravenous infusion of LH-RH with 2 supplementary intramuscular injections has produced ovulation in a patient primed with an FSH-containing material (Pergonal). In other experiments patients pretreated with clomiphene had an increased incidence of ovulation. In men with oligospermia only slight improvement has been obtained. Most of the data presented were obtained using highly purified material of porcine origin.

UR - http://www.scopus.com/inward/record.url?scp=0016311739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016311739&partnerID=8YFLogxK

M3 - Article

C2 - 4611964

AN - SCOPUS:0016311739

VL - 10

SP - 1305

EP - 1313

JO - Israel Medical Association Journal

JF - Israel Medical Association Journal

SN - 1565-1088

IS - 10

ER -